The role of the RS1-NEDD4-YAP1 axis orchestrates epithelial-macrophage interplay in COPD.

backgroundChronic obstructive pulmonary disease (COPD) is a heterogeneous disorder characterized by persistent airflow limitation and is a leading cause of morbidity and mortality worldwide. While cigarette smoking is the primary environmental risk factor, only a subset of smokers develops clinically significant COPD, indicating roles for genetic susceptibility and dysregulated cellular responses. Although traditionally viewed as an immune-driven inflammatory disease, recent evidence underscores the active contribution of structural cells-particularly alveolar type II epithelial cells (AT2 cells)-to immune regulation and tissue remodeling.

methodsThis study integrated single-cell transcriptomics, conditional gene knockout mouse models, organoid culture, multiplex immunofluorescence validation, and flow cytometry to investigate the role of the RS1 gene in chronic obstructive pulmonary disease (COPD). Single-cell sequencing technology revealed RS1 as a signature gene of AT2 cells. Using cigarette smoke (CS)-exposed AT2 cell-specific RS1 knockout mice and organoids as models, we elucidated the mechanisms by which RS1 regulates AT2 cells and its associated role in COPD pathogenesis through molecular experiments.

resultsSingle-cell RNA sequencing analysis revealed that RS1 is specifically expressed in AT2 cells in COPD models, and its expression exhibits interactions with immune cells. By constructing a COPD mouse model with AT2 cell-specific RS1 knockout (Sftpc

conclusionRS1 suppresses AT2 cell proliferative capacity and promotes macrophage infiltration. RS1 interacts with NEDD4 to mediate YAP1 dephosphorylation and nuclear translocation, and treatment with the selective NEDD4 inhibitor I3C further suppresses TGFB1 expression and macrophage infiltration.